Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan (ULYSSES)
1 other identifier
observational
150
2 countries
14
Brief Summary
Conflicting evidence exist in the literature on the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic chest CT scan. The primary aim of this prospective, observational, multicenter study is to evaluate the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic CT scans. Secondary aims are related to the utility of bronchoscopy to detect occult malignancies, the source of the bleeding and the clinical features of the cohort
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2022
Typical duration for all trials
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 21, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedAugust 21, 2024
August 1, 2024
2 years
November 21, 2022
August 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the proportion of patients with haemoptysis and negative/non-diagnostic CT scans in whom bronchoscopy allows an aetiological (i.e., endoscopic and/or microbiological and/or anatomopathological) diagnosis
The primary aim of the study is to evaluate the proportion of patients with haemoptysis and negative/non-diagnostic CT scans in whom bronchoscopy allows an aetiological (i.e., endoscopic and/or microbiological and/or anatomopathological) diagnosis
One year
Secondary Outcomes (6)
To evaluate the proportion of patients in whom bronchoscopy may detect occult endobronchial neoplasms (not detected with chest CT scan)
One year
To evaluate the proportion of patients in whom bronchoscopy may identify the source of the bleeding
One year
To evaluate the proportion of patients with haemoptysis and negative chest CT scan in whom bronchoscopic findings may induce variation in the treatment of the patients
One year
To evaluate the proportion of patients with a negative bronchoscopy at baseline, in whom a an endoscopic examination performed during the follow-up for recurrent haemoptysis may allow an aetiological diagnosis
One year
To evaluate the proportion of patients with a negative chest CT scan and bronchoscopy in whom lung cancer may be diagnosed during the follow-up
One year
- +1 more secondary outcomes
Study Arms (1)
Patients with haemoptysis and negative/non-diagnostic CT scan
Patients with haemoptysis and negative/non-diagnostic CT scan (i.e. with focal peripheral lung fibrosis, calcified parenchymal nodules with a maximum diameter \<5 mm, linear subsegmental atelectasis, hilar-mediastinal lymph nodes with a short axis \<1 cm, pleural thickening/pleural calcification and focal area of emphysema with a diameter \<1 cm) for whom bronchoscopy is deemed necessary to obtain an aetiological diagnosis.
Interventions
During bronchoscopy endobronchial biopsy, transbronchial biopsy, transbronchial needle aspiration, bronchial washing, bronchoalveolar lavage, EBUS-TBNA and EUS-B-FNA may be performed
Eligibility Criteria
Adult patients (i.e., ≥18 years) of any nationality (inpatients and outpatients) with haemoptysis of unknown aetiology and negative chest CT scan/with CT scan showing non-diagnostic findings (i.e. focal peripheral lung fibrosis, calcified parenchymal nodules with a maximum diameter \<5 mm, linear subsegmental atelectasis, hilar-mediastinal lymph nodes with a short axis \<1 cm, pleural thickening/pleural calcification and focal area of emphysema with a diameter \<1 cm), in whom bronchoscopy is deemed necessary to obtain an aetiological diagnosis.
You may qualify if:
- ≥18 years old
- Haemoptysis of unknown origin
- Negative or non-diagnostic chest CT scan
You may not qualify if:
- Known bleeding lesions of the upper or lower respiratory airways
- Chest CT scan diagnostic for hemoptysis etiology
- Refusal to sign the informed consent
- Refusal of bronchoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
- Respiratory Unit, ASST Papa Giovanni XVIII
Bergamo, Italy
- Interventional Pulmonology Unit, Policlinico S. Orsola-Malpighi
Bologna, Italy
Department of Pulmonary and Critical Care Medicine, Sant'Anna Hospital
Como, Italy
Respiratory Unit, ASST Lodi
Lodi, Italy
Respiratory Unit, ASST Santi Paolo e Carlo
Milan, 20142, Italy
- Respiratory Unit, Sacco Hospital, ASST Fatebenefratelli-Sacco
Milan, Italy
Respiratory Unit, San Gerardo Hospital, ASST Monza
Monza, Italy
Interventional Pulmonology Unit, Dept of Pulmonology, Oncology and Hematology, Cardarelli Hospital
Naples, Italy
- Respiratory Unit, IRCCS Foundation Policlinico San Matteo
Pavia, Italy
Pulmonology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia
Reggio Emilia, Italy
- Interventional Pulmonology Unit, Policlinico Agostino Gemelli
Roma, Italy
- Respiratory Unit, A.O.U. Città della Salute e della Scienza di Torino
Torino, Italy
Department of Pulmonology, University Hospital of Udine (ASUFC)
Udine, Italy
Interventional Pulmonology Unit, Respiratory Department, University Hospital Santa Creu i Sant Pau
Barcelona, Spain
Biospecimen
blood, serum, bronchial/lung tissue, bronchial secretions, BAL fluid, lymph node aspirates
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michele Mondoni, MD
Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan
Central Study Contacts
Michele Mondoni, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Respiratory Medicine
Study Record Dates
First Submitted
November 21, 2022
First Posted
December 2, 2022
Study Start
October 1, 2022
Primary Completion
October 1, 2024
Study Completion
October 1, 2025
Last Updated
August 21, 2024
Record last verified: 2024-08